Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations, the description discloses substantial behavior: ambiguous matches return figi_candidates without asserting a result, unresolved identifiers are explicitly listed under unresolved, LEI/FIGI enrichment degrades gracefully if upstream APIs are unavailable, and every identifier is labeled with its source. This is exactly the kind of behavioral transparency that helps an agent predict tool outcomes.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but nearly every sentence carries useful operational guidance or an edge-case warning. It is front-loaded with the purpose and the critical 'Use FIRST' directive. The structure could be cleaner — the company sub-description is a large parenthetical run-on — yet it remains appropriately detailed for a tool with this much behavioral nuance.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema, the description is remarkably complete: it covers input forms, supported entity types, return-behavior quirks (figi_candidates, unresolved), data sources, fallback behavior, and cross-tool value. An agent has enough context to call the tool correctly and interpret results without further manual discovery.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already covers the value parameter thoroughly, including input formats and the bond issuer-name warning. The description adds meaningful parameter-level semantics by explaining what each supported type resolves to: company returns CIK, ticker, company_name, LEI, ownership, and FIGI; drug returns RxCUI, ingredient, and brand. This goes beyond the schema's bare enum, though much of the value-parameter guidance is duplicated from the schema rather than newly added.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description immediately states the core function: resolving a user-spoken name to canonical identifiers that other tools require as input, reinforced by multiple concrete examples ('What's the ticker for...', 'find the CIK for...'). It also enumerates the supported entity types and, by framing the tool as a name-to-ID resolver, distinguishes it from sibling tools like entity_profile or compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit usage guidance: 'Use FIRST whenever you have a name but need an ID.' It also explains that the tool replaces 2-3 manual lookups, which helps an agent understand its place in the pipeline. However, it does not explicitly state when not to use it or name alternative sibling tools for already-resolved entities or profile retrieval, so it falls short of full exclusion guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

There is substantial overlap among tools in the Pipeworx group: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, and validate_claim all route natural-language queries to the same 5,578 tools and sources, with only subtle differences in mode (beta vs stable, grounded vs standard, single vs multi-part). Similarly, polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, and polymarket_fill_risk are heavily intertwined, making differentiation difficult. Tools like similar, size, history, and scan_dependency from the bundlephobia side are distinct, but the Pipeworx family muddies the set.

Naming Consistency3/5

The bundlephobia tools follow a consistent noun pattern (size, similar, history), and the Pipeworx meta-tools use snake_case verbs (ask_pipeworx, resolve_entity, compare_entities, validate_claim). However, the naming is inconsistent across the two families—bundlephobia's simple nouns (size, similar, history) clash with the verbose descriptive verbs—and naming like ai_visibility_check, scan_competitor_ai_presence, and generate_llms_txt break from the Pipeworx pattern. The set mixes short names, camelCase-ish compounds, and snake_case, so no single consistent convention holds.

Tool Count2/5

35 tools is too many for a server that ostensibly serves two domains (bundle-size analysis and Pipeworx data research). The bundle-size analysis needs only a handful (size, history, similar, recent_searches, scan_dependency), yet there are over 30 tools dominated by a sprawling meta-research layer including multiple ask_pipeworx variants, several polymarket tools, plus meta-cognitive tools (remember, recall, forget, discover_tools) that are not core to either domain. This bloats the surface and makes call routing difficult.

Completeness4/5

Each functional domain is fairly complete: bundlephobia covers size measurement, history, alternatives, search, and dependency vetting; the Pipeworx side covers lookup, research, entity resolution, comparison, verification, subscriptions, and feedback. However, there are gaps—e.g., no tool for directly reading an npm package's README or license beyond scan_dependency's summary, and no explicit tools for some administrative actions like account management or subscription editing beyond create/cancel/list. The completeness is strong for what's advertised but not exhaustive.